Teva Pharmaceuticals USA initiated the voluntary recall on October 7, 2025, with Amerisource Health Services following suit on October 26. In total, nearly 590,000 bottles across 55 separate lots are affected. The recalled bottles contain between 100 and 1,000 capsules each, with specific quantities for each strength: 181,659 bottles of 1 mg, 291,512 bottles of 2 mg, and 107,673 bottles of 5 mg.
Prazosin hydrochloride is a crucial medication used to relax blood vessels and lower blood pressure, thereby helping to prevent strokes, heart attacks, and kidney failure. It is also sometimes prescribed off-label to manage nightmares and sleep disturbances associated with post-traumatic stress disorder (PTSD).
Guidance for Patients and Healthcare Providers
Both the FDA and Teva Pharmaceuticals are urging patients currently taking the recalled prazosin to consult their healthcare provider or pharmacist before discontinuing the medication. Stopping treatment abruptly could pose a greater health risk than continuing to take the medication, depending on the individual’s condition. Healthcare providers are encouraged to discuss alternative treatment options with their patients.
Teva Pharmaceuticals has stated its commitment to patient safety and product quality, noting that it had not received any relevant complaints related to the recalled product. Recall letters have been sent to customers with instructions for returning affected bottles.
Broader Implications for Drug Safety
This incident is part of a larger trend of recalls involving blood pressure and other medications due to nitrosamine impurities. The FDA has been increasingly vigilant in monitoring for these contaminants since similar recalls affected other drugs in recent years. The complexity of global pharmaceutical supply chains and manufacturing processes highlights the ongoing challenges in ensuring consistent drug quality and safety. The recall serves as a potent reminder of the importance of rigorous drug safety standards and transparent communication when potential risks are identified.
For complete cooking times, go to the next page or click the Open button (>), and don't forget to SHARE with your Facebook friends.
